These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3154313)

  • 41. [The side effects of angiotensin-converting enzyme inhibitors in the treatment of arterial hypertension].
    Babadzhan VD; Lapshina LA; Shkapo VL
    Lik Sprava; 2000; (3-4):54-9. PubMed ID: 10921262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alternative first-line therapies in geriatric hypertension.
    Sloan RW
    Geriatrics; 1989 Apr; 44(4):61-4, 69-72, 74. PubMed ID: 2647588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
    Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Combination therapy with ACE inhibitors and angiotensin receptor antagonists].
    Kisters K
    Internist (Berl); 1999 Jun; 40(6):678-9. PubMed ID: 10420325
    [No Abstract]   [Full Text] [Related]  

  • 45. [Angiotensin II antagonists versus ACE inhibitors in the treatment of raised blood pressure].
    Andersen RS; Christensen S
    Ugeskr Laeger; 2001 Dec; 163(50):7036-9. PubMed ID: 11794033
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of hypertension from volume to vasoconstriction: The ACE up your sleeve.
    Stanley JC; Samson RH
    Semin Vasc Surg; 2002 Dec; 15(4):225-36. PubMed ID: 12478497
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiotensin-converting enzyme inhibitors for systemic hypertension in young and elderly patients.
    Schnaper HW
    Am J Cardiol; 1992 Apr; 69(10):54C-58C. PubMed ID: 1546640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The use of angiotensin converting enzyme inhibitors in practice].
    Zschiedrich H
    Arzneimittelforschung; 1993 Feb; 43(2A):271-3. PubMed ID: 8498977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.
    Wing LM; Reid CM; Ryan P; Beilin LJ; Brown MA; Jennings GL; Johnston CI; McNeil JJ; Macdonald GJ; Marley JE; Morgan TO; West MJ;
    N Engl J Med; 2003 Feb; 348(7):583-92. PubMed ID: 12584366
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angioedema after local trauma in a patient on angiotensin-converting enzyme inhibitor therapy.
    Simmons BB; Folsom MA; Bryden LA; Studdiford JS
    J Am Board Fam Med; 2008; 21(6):577-9. PubMed ID: 18988727
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of ACE inhibitors in the management of hypertension.
    Ramsay LE; Yeo WW
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():1-4; discussion 4-5. PubMed ID: 2283649
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia.
    Gadzhanova S; Roughead EE; Bartlett LE
    Eur J Clin Pharmacol; 2016 Jun; 72(6):765-71. PubMed ID: 26961086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.
    Matchar DB; McCrory DC; Orlando LA; Patel MR; Patel UD; Patwardhan MB; Powers B; Samsa GP; Gray RN
    Ann Intern Med; 2008 Jan; 148(1):16-29. PubMed ID: 17984484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin II type 1 receptor blockade: a novel therapeutic concept.
    Johnston CI
    Blood Press Suppl; 2000; 1():9-13. PubMed ID: 11059629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of angiotensin converting enzyme inhibitors in combination with other antihypertensive agents.
    Pickering TG
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):73S-78S. PubMed ID: 2009154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin-converting enzyme inhibitors in hypertension. A dozen years of experience.
    Materson BJ; Preston RA
    Arch Intern Med; 1994 Mar; 154(5):513-23. PubMed ID: 8122944
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension.
    Messerli FH; Oparil S; Feng Z
    Am J Cardiol; 2000 Dec; 86(11):1182-7. PubMed ID: 11090788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.
    Tikkanen T; Tikkanen I; Rockell MD; Allen TJ; Johnston CI; Cooper ME; Burrell LM
    Hypertension; 1998 Oct; 32(4):778-85. PubMed ID: 9774379
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats.
    Becker RH; Baldes L; Treudler M
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S35-9. PubMed ID: 2474099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [ACE inhibitor-diuretic combinations in the treatment of arterial hypertension].
    Krivitzky A
    Rev Prat; 1993 Dec; 43(20 Suppl):32-5. PubMed ID: 8146581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.